SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : American Bio Medica (ABMC) drug test solution -taking off!
ABMC 0.0400+22.7%Jan 10 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Anderfuren who wrote (559)10/15/1999 10:38:00 AM
From: Skywatcher  Read Replies (1) of 629
 
American Bio Medica Files Second Patent Infringement and Trademark
Dilution Lawsuit
KINDERHOOK, N.Y.--(BUSINESS WIRE)--October 15, 1999--American Bio Medica Corp. (NASDAQ: ABMC - news) today announced that it filed a
lawsuit in the United States District Court for the Southern District of Alabama against Larry Hartselle (and his company Instant Drug Detection), Gulf Supply Co., Inc. of Mobile, Alabama and Drug Detection Devices, Ltd. of Atlanta, Georgia. The suit alleges infringement of a U.S. design patent owned by American Bio Medica, trademark dilution of the Company's Rapid Drug Screen trademark and unfair competition.
The Company claims that Instant Drug Detection is marketing a drug screening test that is a copy of American Bio Medica's Rapid Drug Screen(TM) on-site drug test, resulting in confusion in the
marketplace. ABMC also claims that another copy of the Rapid Drug Screen is manufactured by Drug Detection Devices and distributed by Gulf Supply Co., thus resulting in further confusion in the marketplace.
The Company has sought injunctive relief to prevent consumers' confusion, mistake or deception as a result of the defendants' alleged use of the Company's design, trademarks or service marks, as well
as to prevent dilution of the Company's trademarks and service marks. The Company also seeks monetary damages.
''American Bio Medica continues to vigilantly defend its proprietary products and rights in the marketplace with lawsuits against parties that we learn are manufacturing and marketing knock off products of our patented drug tests,'' stated American Bio Medica CEO and Chairman Stan Cipkowski. ''We will continue our efforts to block all companies that infringe upon our patent and trademark rights and in the process harm the consuming public by letting people think that they are
buying the Rapid Drug Screen instead of an unauthorized copy.''
It's UP on this BIG DOWN day!
can't complain
chris
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News